Literature DB >> 29351126

Incidence and Risk Factors for Falls in Women With End-Stage Hip Osteoarthritis.

Hisashi Ikutomo1, Koutatsu Nagai2, Keiichi Tagomori1, Namika Miura1, Norikazu Nakagawa1, Kensaku Masuhara3.   

Abstract

BACKGROUND AND
PURPOSE: Fall-induced injuries and resulting deaths are a serious health problem among older adults. The most common risk factors for falls in older adults are muscle weakness, gait deficiencies, and balance deficits. Patients with end-stage hip osteoarthritis (OA) also have many hip dysfunctions, and these all have the potential to increase the risk of falls. However, the incidence and risk factors for falls in patients with end-stage hip OA remain unclear. The aim of this study was to determine the incidence of falls in women with end-stage hip OA and to identify risk factors for falls in this patient population.
METHODS: This study was a cross-sectional analysis. One hundred fifty-three women with end-stage hip OA (mean age = 64.0 years) and 112 age-matched healthy women (mean age = 64.1 years) were analyzed using available data. All participants were examined for the number and circumstances of falls in the past year. The circumstances of falls included the location, time, direction, cause, and injury. We examined the outcome of hip function, ambulatory ability, physical activity, and limping severity in women with end-stage hip OA. Multivariate logistic regression analysis was used to identify factors influencing falls in women with hip OA.
RESULTS: The incidence of at least 1 fall in the past year was significantly higher in women with end-stage hip OA (30.1%) than in healthy women (12.5%) (P < .001). Falls in women with end-stage hip OA were most often caused by tripping and falling forward during the daytime. The majority of falls (65.2%) resulted in injuries and 13.0% resulted in fractures. The occurrence of a fall significantly correlated with limping (odds ratio = 3.26, 95% confidence interval = 1.49-7.14, P = .003) and knee extensor muscle strength (odds ratio = 0.22, 95% confidence interval = 0.05-0.85, P = .029).
CONCLUSIONS: Women with end-stage hip OA have an increased risk of falls and fall-induced injuries. The prevention of falls in this vulnerable population should be a priority among health care practitioners. In particular, women who are limping and have reduced lower knee extensor strength should take care to avoid falls.

Entities:  

Mesh:

Year:  2019        PMID: 29351126     DOI: 10.1519/JPT.0000000000000156

Source DB:  PubMed          Journal:  J Geriatr Phys Ther        ISSN: 1539-8412            Impact factor:   3.381


  5 in total

1.  Sports Therapy Interventions Following Total Hip Replacement.

Authors:  Heidrun Beck; Franziska Beyer; Franziska Gering; Klaus-Peter Günther; Cornelia Lützner; Achim Walther; Maik Stiehler
Journal:  Dtsch Arztebl Int       Date:  2019-01-07       Impact factor: 5.594

2.  Three-dimensional foot trajectory in female patients with end-stage hip osteoarthritis during walking.

Authors:  Yu Kiko; Taiki Ogata; Hirotaka Uchitomi; Masaaki Matsubara; Yoshihiro Miyake; Yoshiaki Wada
Journal:  Sci Rep       Date:  2022-06-14       Impact factor: 4.996

3.  Analysis of the Associations between Arthritis and Fall Histories in Korean Adults.

Authors:  Jung Woo Lee; Seong Hun Kang; Hyo Geun Choi
Journal:  Int J Environ Res Public Health       Date:  2021-04-03       Impact factor: 3.390

4.  Determining the Profile of People with Fall Risk in Community-Living Older People in Algarve Region: A Cross-Sectional, Population-Based Study.

Authors:  Carla Guerreiro; Marta Botelho; Elia Fernández-Martínez; Ana Marreiros; Sandra Pais
Journal:  Int J Environ Res Public Health       Date:  2022-02-16       Impact factor: 3.390

5.  Effect of a programme of muscular endurance, balance and gait exercises with and without the use of flexible and minimalist shoes in older women with medial knee osteoarthritis: study protocol for a randomised controlled trial.

Authors:  Daniel Borges Pereira; Tatiane Silva de Souza; Carolina Tayama Fuzinato; Rodrigo Jugue Hagihara; Ana Paula Ribeiro
Journal:  BMJ Open       Date:  2022-09-20       Impact factor: 3.006

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.